Sign in

CIK 0001527753 · Non-accelerated filer<br>Smaller reporting company

Personalis, Inc.

Sign in to watch
Ticker
PSNL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
275411038
Phone
650-752-1300
Business address
6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
  1. 4 Grant or award General Counsel acquired 18,600 shares (grant or award)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award President and CEO acquired 230,000 shares (grant or award)
  5. 4 Grant or award Director acquired 30,940 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 4 Open-market sale Chief Medical Officer sold 632 shares at $3.91 ($2,471)
  10. 4 Open-market sale Chief Financial Officer sold 632 shares at $3.91 ($2,471)
  11. 4 Open-market sale Chief Medical Officer sold 1,565 shares at $3.29 ($5,149)
  12. 4 Open-market sale Chief Financial Officer sold 3,440 shares at $3.29 ($11,318)
  13. 4 Open-market sale General Counsel sold 1,832 shares at $3.24 ($5,936)
  14. 4 Open-market sale Chief Medical Officer sold 6,818 shares at $3.24 ($22,090)
  15. 4 Open-market sale Chief Financial Officer sold 6,818 shares at $3.24 ($22,090)
  16. 4 Open-market sale Chief Financial Officer sold 4,187 shares at $3.59 ($15,031)
  17. 4 Open-market sale Chief Medical Officer sold 421 shares at $3.59 ($1,511)
  18. 4 Grant or award Director acquired 10,770 shares (grant or award)
  19. 4 Grant or award Director acquired 10,770 shares (grant or award)
  20. 4 Grant or award Director acquired 10,770 shares (grant or award)

Page 16 of 28 · 557 filings